SCHEMBL3660653

SCHEMBL3660653

CC(=C[C@H](CC(C)(C)C)c1ccc(Br)cc1)CC(CCOC(N)=O)(N[S@+]([O-])C(C)(C)C)c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3660652 0.73 CYP19A1 (0.33)
SCHEMBL3768869 0.70
SCHEMBL3657597 0.67 SMN1; SMN2 (0.30)
SCHEMBL3657601 0.67 SMN1; SMN2 (0.30)
SCHEMBL9962948 0.65
SCHEMBL3661323 0.65 BACE1 (0.31)
SCHEMBL3210998 0.63 KMT2A (0.35)
SCHEMBL9962945 0.62 KMT2A (0.33)
SCHEMBL12165947 0.62 RIPK1 (0.33)
SCHEMBL1978544 0.61 KMT2A (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2220052-B1 CYCLIC UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1 VITAE PHARMACEUTICALS INC (US) 2015-03-25 EP disclosed
EP-2220052-A1 CYCLIC UREA INHIBITORS OF 11 -HYDROXYSTEROID DEHYDROGENASE 1 Vitae Pharmaceuticals, Inc. (US) 2010-08-25 EP disclosed
WO-2009061498-A1 CYCLIC UREA INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 VITAE PHARMACEUTICALS, INC. (US) 2009-05-14 WO disclosed